BGI Co-Win Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
40
- Portfolio
-
27
- Exits
-
11
BGI Co-Win General Information
Company Description
Founded in 2016, BGI Co-Win is a corporate venture capital arm of BGI headquartered in Shenzhen, China. The firm seeks to invest in medical technology, gene technology, and biomedical companies.
Business Details
Website
bgi-cowin.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- New World Center, 6009 Yitian Rd, Futian District
- Room 1303-1305
- Shenzhen, Guangdong 518083
- China
BGI Co-Win Investments (40)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ThinkMotion | 12-Jun-2025 | Early Stage VC | Machinery (B2B) | Generating Revenue | ||
| Agile Bio | 11-Feb-2025 | Medical Supplies | Generating Revenue | |||
| Tiyi Technology | 12-Dec-2024 | Precious Metals and Minerals Mining | Generating Revenue | |||
| Silver KBO Holding | 04-Feb-2024 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| LeadBio Tech | 13-Nov-2023 | Biotechnology | Generating Revenue | |||
| Wknife | 07-Aug-2023 | Clinics/Outpatient Services | Generating Revenue | |||
| Jarvis Bio | 25-Jul-2023 | Diagnostic Equipment | Generating Revenue | |||
| Ubrigene | 18-Apr-2023 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Shanghai Etopia Building Technology | 01-Mar-2023 | PE Growth/Expansion | Other Commercial Products | Generating Revenue | ||
| Genolmmune Therapeutics | 28-Dec-2022 | Later Stage VC | Drug Discovery | Generating Revenue |
BGI Co-Win Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Okay Biotechnology | 11-Dec-2025 | Merger/Acquisition | |
| Ab&B Bio-Tech Co | 11-Aug-2025 | ||
| Jiangsu Hanbon Science and Technology | 15-May-2025 | ||
| Funik Ultrahard Materials | 01-Jan-2025 | ||
| EVIRTH | 01-Nov-2024 | ||
| YZY Bio | 25-Sep-2023 | ||
| MGI Tech | 09-Sep-2022 | ||
| CANbridge Pharma | 10-Dec-2021 | ||
| Koalson | 23-Dec-2020 | Merger/Acquisition | |
| Menovo | 07-Apr-2017 | IPO |
BGI Co-Win Investments by Industry, Year, and Region
BGI Co-Win Co-Investors (31)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| BGI Genomics | 2 |
|
|
||
| Finnova Capital |
|
|
|||
| CLSA Capital Partners |
|
|
|||
| Detong Capital |
|
|
|||
| IDG Capital |
|
|
BGI Co-Win FAQs
-
What is BGI Co-Win?
Founded in 2016, BGI Co-Win is a corporate venture capital arm of BGI headquartered in Shenzhen, China.
-
When was BGI Co-Win founded?
BGI Co-Win was founded in 2016.
-
Where is BGI Co-Win headquartered?
BGI Co-Win is headquartered in Shenzhen, China.
-
What is BGI Co-Win's total asset value?
BGI Co-Win has around in total assets under management.
-
How many investments has BGI Co-Win made?
BGI Co-Win has made 40 investments.
-
What has BGI Co-Win invested in?
BGI Co-Win has made numerous investments in companies like ThinkMotion, Agile Bio, and Tiyi Technology within the Machinery (B2B), Medical Supplies, and Precious Metals and Minerals Mining industries.
-
What has BGI Co-Win invested in recently?
BGI Co-Win's latest investment was on 12-Jun-2025 in ThinkMotion, a company within the Machinery (B2B) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process